A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)
Clinical trial NCT07163364 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07163364
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-31
- Primary completion
- 2026-10-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.